Clinical Trials
21 trialsNCT05236764 2025-10-30
HAPLOTAB
Baylor College of Medicine
Phase NA Active not recruiting
NCT04526886 2025-10-06
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT03938324 2025-07-28
PiCASO
Duke University
Phase NA Completed
NCT05315908 2024-02-28
COVID-19 Testing in Underserved and Vulnerable Populations
University of California, San Diego
Phase NA Terminated
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT02728596 2022-10-20
TrACER
SWOG Cancer Research Network
Phase NA Completed
NCT04246021 2022-01-04
Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
King Hussein Cancer Center
Phase NA Completed
NCT02964325 2021-08-19
MIPLATE
Terumo BCTbio
Phase NA Terminated
NCT01768845 2021-06-14
Unrelated Umbilical Cord Blood (UBC)Transplantation
West Virginia University
Phase NA Completed
NCT01807091 2021-03-05
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
University of Washington
Phase NA Completed
NCT03387033 2021-03-01
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
Duke University
Phase NA Terminated
NCT00856388 2019-11-13
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Roswell Park Cancer Institute
Phase NA Completed
NCT01572922 2019-06-11
Massive Iron Deposit Assessment
St. Jude Children's Research Hospital
Phase NA Completed
NCT01499147 2018-11-08
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
University of Illinois at Chicago
Phase NA Completed
NCT01872819 2018-07-11
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
University of Washington
Phase NA Completed
NCT00400686 2018-02-22
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
The Cleveland Clinic
Phase NA Completed
NCT01831232 2017-11-17
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Fred Hutchinson Cancer Center
Phase NA Completed
NCT00258440 2017-05-09
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT00255684 2016-11-03
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
University of Rochester
Phase NA Terminated
NCT02007863 2015-12-28
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia
University of Miami
Phase NA Completed
NCT00594308 2014-10-06
In-Vivo Activated T-Cell Depletion to Prevent GVHD
Indiana University
Phase NA Terminated